Qiagen, the new giant in next-gen sequencing tools?
Yet again, a new acquisition in this beginning of 2015. Enzymatics, the Boston-area based Biotech company and…
January 17, 2015 - 2 minutes
Germany
Promising Agreement Signed for Regenerative Medicine
Heraeus Medical signed an agreement with Locate Therapeutics to license the intellectual property surrounding the use…
December 10, 2014 - 2 minutes
The First Gene Therapy Drug Will Be Sold at Record €1,1M Price
What could you buy with €1,1M euros? A house? Or a single prescription for a new…
December 1, 2014 - 3 minutes
One Billion Strategic Oncology Alliance for the Second Largest Antibody Technology Platform
Oxford BioTherapeutics and Menarini Group have initiated the first-in-human clinical study of OBT357, a novel enhanced…
November 28, 2014 - 2 minutes
Curetis Raised Additional €14.5M to Diagnose Severe Infectious Diseases
Curetis AG, a developer of next-level molecular diagnostic solutions, has closed a EUR 14.5 million extension of…
November 27, 2014 - 2 minutes
Munich: Why is it One of the Best Biotech Cluster in Europe ?
The biotech sector in the Greater Munich area continues to demonstrate significant growth in revenue…
November 23, 2014 - 3 minutes
After AstraZeneca Turned Down Pfizer’s Bid, Merck Took the Opportunity
Pharmaceutical giants Merck and Pfizer have agreed a deal to develop and market immunotherapy agents…
November 22, 2014 - 2 minutes
BIO-Europe, “The place to be for partnering in Europe”
The title may seem a bit catchy, but that’s what lot of companies told me during…
November 13, 2014 - 3 minutes
Review : Ebola, The True Story
The first outbreaks of Ebola (also known as Ebola haemorrhagic fever) have occurred in isolated…
October 30, 2014 - 26 minutes
European’s First Personalized Vaccines to Treat Brain Cancer
A novel concept of fully personalized therapeutic cancer vaccines, called Glioma Actively Personalized VAccine Consortium…
October 20, 2014 - 3 minutes
A Smart Collaboration to Diagnostic and Fight Cancer
New Oncology announced that it has entered into a collaboration agreement with Gustave Roussy Cancer Campus,…
October 16, 2014 - 3 minutes
Recently Launched Company Rigontec already Raised 9,45M Euros against Cancer
Rigontec GmbH, a German privately held biopharmaceutical company developing RNA-based immunotherapeutics for the treatment of…
October 15, 2014 - 2 minutes
